Sanofi-Aventis: Company Profile and SWOT Analysis
Synopsis
ICD Research's 'Sanofi-Aventis: Company Profile and SWOT Analysis' contains in depth information and data about the company and its operations. The profile contains a company overview, business description, SWOT analysis, key facts, Competitive benchmarking, information on products and services, financial ratios, details of locations and subsidiaries, plus information on key news events affecting the company.
Summary
This SWOT analysis and company profile is a crucial resource for industry executives and anyone looking to gain a better understanding of the company's business.
ICD Research's 'Sanofi-Aventis: Company Profile and SWOT Analysis' report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.
Scope
Reasons To Buy
Key Highlights
Sanofi-Aventis (Sanofi) is a leading global pharmaceutical company that discovers, develops and distributes therapeutic solutions. It offers an extensive portfolio of prescription drugs, vaccines, generics and consumer healthcare products to traditional markets and emerging countries. The company's products are offered in 170 countries across the world. Sanofi has a commercial presence in 100 countries. Its business activities are classified under two segments, pharmaceuticals and vaccines. Its pharmaceutical activity revolves around six therapeutic areas, diabetes, oncology, thrombosis and cardiovascular, central nervous system (CNS), and internal medicine. It also offers other pharmaceutical products in Consumer Health Care (CHC) and other prescription drugs, including generics. The company offers vaccines in five areas, influenza vaccines, pediatric combination vaccines, adult and adolescent booster vaccines, meningitis vaccines and travel and endemic vaccines. Sanofi is headquartered in Paris, France.
ICD Research's 'Sanofi-Aventis: Company Profile and SWOT Analysis' contains in depth information and data about the company and its operations. The profile contains a company overview, business description, SWOT analysis, key facts, Competitive benchmarking, information on products and services, financial ratios, details of locations and subsidiaries, plus information on key news events affecting the company.
Summary
This SWOT analysis and company profile is a crucial resource for industry executives and anyone looking to gain a better understanding of the company's business.
ICD Research's 'Sanofi-Aventis: Company Profile and SWOT Analysis' report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.
Scope
- Examines and identifies key information and issues about Sanofi-Aventis for business intelligence requirements
- Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported
- Provides analysis on financial ratios along with a competitor benchmarking section
- The profile also contains information on business operations, company history, major products and services, prospects, key employees, locations and subsidiaries
Reasons To Buy
- Quickly enhance your understanding of the company
- Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry
- Increase business/sales activities by understanding your competitors’ businesses better
- Recognize potential partnerships and suppliers
- Obtain yearly profitability figures
Key Highlights
Sanofi-Aventis (Sanofi) is a leading global pharmaceutical company that discovers, develops and distributes therapeutic solutions. It offers an extensive portfolio of prescription drugs, vaccines, generics and consumer healthcare products to traditional markets and emerging countries. The company's products are offered in 170 countries across the world. Sanofi has a commercial presence in 100 countries. Its business activities are classified under two segments, pharmaceuticals and vaccines. Its pharmaceutical activity revolves around six therapeutic areas, diabetes, oncology, thrombosis and cardiovascular, central nervous system (CNS), and internal medicine. It also offers other pharmaceutical products in Consumer Health Care (CHC) and other prescription drugs, including generics. The company offers vaccines in five areas, influenza vaccines, pediatric combination vaccines, adult and adolescent booster vaccines, meningitis vaccines and travel and endemic vaccines. Sanofi is headquartered in Paris, France.
Contents
1 BUSINESS ANALYSIS1.1 Company Overview
1.2 Business Description
1.3 Major Products and Services
2 ANALYSIS OF KEY PERFORMANCE INDICATORS
2.1 Five Year Snapshot: Overview of Financial and Operational Performance Indicators
2.2 Key Financial Performance Indicators
2.2.1 Revenue and Operating Profit
2.2.2 Asset, Liabilities and Capex
2.2.3 Net Debt vs. gearing Ratio
2.2.4 Operational Efficiency
2.2.5 Solvency
2.2.6 Valuation
2.3 Competitive benchmarking
2.3.1 Market Capitalization
2.3.2 Efficiency
2.3.3 Capital Expenditure
2.3.4 Valuation
2.3.5 Turnover - Inventory and Asset
2.3.6 Liquidity
3 MERGERS & ACQUISITIONS AND PARTNERSHIPS
3.1 M&A and Partnerships Strategy
4 RECENT DEVELOPMENTS
5 SWOT ANALYSIS
5.1 SWOT Analysis - Overview
5.2 Strengths
5.3 Weaknesses
5.4 Opportunities
5.5 Threats
6 HISTORY
7 SANOFI-AVENTIS - KEY EMPLOYEES
8 KEY EMPLOYEE BIOGRAPHIES
9 LOCATIONS AND SUBSIDIARIES
9.1 Head Office
9.2 Other locations and Subsidiaries
10 APPENDIX
10.1 Methodology
10.2 Ratio Definitions
10.3 Disclaimer
LIST OF TABLES
Table 1: Major Products and Services
Table 2: Key Ratios - Annual
Table 3: Key Ratios - Interim
Table 4: Key Capital Market Indicators
Table 5: Sanofi-Aventis, History
Table 6: Sanofi-Aventis, Key Employees
Table 7: Key Employee Biographies
Table 8: Sanofi-Aventis, Subsidiaries
Table 9: Sanofi-Aventis, Locations
LIST OF FIGURES
Figure 1: Revenue and Operating Profit
Figure 2: Financial Position
Figure 3: Net Debt vs. Gearing Ratio
Figure 4: Operational Efficiency
Figure 5: Solvency
Figure 6: Valuation
Figure 7: Market Capitalization
Figure 8: Efficiency
Figure 9: Capital Expenditure
Figure 10: Valuation
Figure 11: Turnover - Inventory and Asset
Figure 12: Liquidity
COMPANIES MENTIONED
Sanofi-Aventis Skip to top